Hetero launches generic Lapatinib under the brand name HERTAB in India Farhat Nasim12 Jan 2019 12:14 PM ISTHERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose...
Hetero gets DCGI nod to market anti-retroviral FDC tablets Ruby Khatun Khatun17 Nov 2017 10:45 AM ISTNew Delhi: Drug firm Hetero said it has received the Drug Controller General of India's approval to launch generic fixed-dose combination...